eClinicalMed Profile Banner
eClinicalMedicine – The Lancet Discovery Science Profile
eClinicalMedicine – The Lancet Discovery Science

@eClinicalMed

Followers
8K
Following
2K
Media
2K
Statuses
7K

Gold open access clinical journal, part of @TheLancet Discovery Science, influencing clinical practice and strengthening health. IF: 9·6.

London UK - Boston USA
Joined May 2018
Don't wanna be here? Send us removal request.
@eClinicalMed
eClinicalMedicine – The Lancet Discovery Science
9 days
📢NEW: June issue now online featuring #asthma, #stroke, #sarcoma, #ulcerativecolitis, #TB, #anxiety, #schizophrenia and much more with our editorial on the rising burden of pollen allergy. …all available #OpenAccess❗️. Read more here: Attribution: Getty
Tweet media one
1
1
8
@eClinicalMed
eClinicalMedicine – The Lancet Discovery Science
10 hours
Total neoadjuvant therapy integrating long-course radiotherapy with trifluridine/tipiracil for locally advanced #rectalcancer: a phase 2 trial. TAS-102 concurrent with preoperative radiotherapy led to a high pCR rate (32%) with acceptable toxicity.
Tweet media one
1
1
3
@eClinicalMed
eClinicalMedicine – The Lancet Discovery Science
2 days
A phase 2 study of tislelizumab combined with bevacizumab and chemotherapy as first-line treatment for persistent, recurrent, or metastatic cervical cancer. This regimen showed promising efficacy with favorable safety profile as first-line treatment.
Tweet media one
0
0
0
@eClinicalMed
eClinicalMedicine – The Lancet Discovery Science
6 days
Predicting Cardiovascular deterioration in a paediatric intensive care unit: a machine learning modelling study. This novel approach showed improved performance over existing clinical scoring systems and could serve as a clinical decision support tool. #AI
Tweet media one
0
1
1
@eClinicalMed
eClinicalMedicine – The Lancet Discovery Science
6 days
RT @TheLancet: In the past 50 years, childhood vaccines have saved an estimated 154 million lives* 💉🌏 . We cannot afford to backtrack on th….
0
167
0
@eClinicalMed
eClinicalMedicine – The Lancet Discovery Science
6 days
RT @Erman_Akkus: 🏥TNT with TAS-102 in LA rectal cancer.@eClinicalMed . ➡️Long course CRT with TAS-102 > 2 cycles TA-102 plus Oxa > surgery….
0
24
0
@eClinicalMed
eClinicalMedicine – The Lancet Discovery Science
7 days
Evaluating axillary lymph node metastasis risks in breast cancer patients via Semi-ALNP: a multicenter study. Semi-ALNP, which is based on the MLP algorithm, has high accuracy in assessing the statuses of ALNs across all types of BC patients. #BreastCancer
Tweet media one
0
0
0
@eClinicalMed
eClinicalMedicine – The Lancet Discovery Science
7 days
RT @TheLancet: There is an urgent need to expand access to life-saving transplants. On July 7, join a webinar where experts will discuss n….
0
10
0
@eClinicalMed
eClinicalMedicine – The Lancet Discovery Science
10 days
Hannah Linne, Senior Editor, will be attending #RCOG2025 and welcomes queries from attendees. @TheLancet journals are committed to supporting you on every stage of your publication journey. Learn more about our scope and global reach & impact here:
Tweet media one
0
0
1
@eClinicalMed
eClinicalMedicine – The Lancet Discovery Science
11 days
RT @LancetGastroHep: New @eClinicalMed - Clinical management of Clostridioides difficile infection with faecal microbiota transplantation:….
0
4
0
@eClinicalMed
eClinicalMedicine – The Lancet Discovery Science
13 days
Prevention of sacituzumab govitecan-related neutropenia and diarrhea in patients with HER2-negative advanced breast cancer. Primary prophylactic G-CSF and loperamide led to a clinically relevant reduced incidence and severity of neutropenia and diarrhea.
Tweet media one
0
0
0
@eClinicalMed
eClinicalMedicine – The Lancet Discovery Science
13 days
RT @Thoracic_PubMed: .@eClinicalMed.📚 Single-arm, Phase 2 trial .📝 Trial ID: NCT03254004 .👥 70 patients .🧑‍⚕️ Stage I lung adenocarcinom….
0
1
0
@eClinicalMed
eClinicalMedicine – The Lancet Discovery Science
15 days
Respiratory syncytial virus-attributable hospitalizations among adults in high- and middle-income countries: application of the GBD framework. Highlights the substantial adult RSV disease burden and illustrates considerable geographic variability. #RSV
Tweet media one
0
0
3
@eClinicalMed
eClinicalMedicine – The Lancet Discovery Science
16 days
RT @SalehAlessy: In a new article in @eClinicalMed , we highlighted the cancer care for Young Adults (<50), as part of our fantastic resear….
0
6
0
@eClinicalMed
eClinicalMedicine – The Lancet Discovery Science
17 days
Efficacy and safety of human fibrinogen concentrate (BT524) in patients with major #haemorrhage undergoing major orthopaedic or abdominal surgery: an RCT. FC was non-inferior to FFP/Cryo for the management of clinically relevant intraoperative bleeding.
Tweet media one
0
0
1
@eClinicalMed
eClinicalMedicine – The Lancet Discovery Science
17 days
RT @Erman_Akkus: ⚠️Risk factors for pancreatic cancer.@eClinicalMed . ➡️Umbrella review.🚨New risk factors:.✔️autoimmune liver disease.✔️BRC….
0
52
0
@eClinicalMed
eClinicalMedicine – The Lancet Discovery Science
20 days
Long-term outcome in Wiskott-Aldrich syndrome and X-linked thrombocytopenia patients. The evidence of the heterogeneity of WAS and XLT outcomes could be instrumental to draw updated recommendations for the management of these patients.
Tweet media one
0
1
2
@eClinicalMed
eClinicalMedicine – The Lancet Discovery Science
21 days
RT @TheLancetOncol: ✏️Comments on cancer control in Kuwait, Bahrain, Syria, and in displaced people. 📰Papers on advancing paediatric cancer….
0
3
0
@eClinicalMed
eClinicalMedicine – The Lancet Discovery Science
22 days
Risk of cardiovascular disease among cancer survivors: systematic review and meta-analysis. Cancer survivors had increased risk of CVD and 17 CVD subtypes than non-cancer controls. #cancer #CVD
Tweet media one
0
0
1
@eClinicalMed
eClinicalMedicine – The Lancet Discovery Science
23 days
RT @ophth_advisor: 💭 Depression & Dementia: A Lifelong Connection. #Depression across the life course is associated with an increased risk….
0
1
0